SEC Form 4 · accession 0001225208-15-001663
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P. Phalen
Officer — EVP & President, MedSurg
Period of report
Jan 20, 2015
Accepted (ET)
Jan 20, 2015 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jan 20, 2015 | S | 10,000 | $14.5407 | D | 108,645 | D | |
| Common StockF4 | holding | — | — | — | 2,433 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.49 to $14.58, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F4Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.